![]() |
|
Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
Korean J Intern Med. 2024;39(4):577-589. Published online 2024 Jun 13 DOI: https://doi.org/10.3904/kjim.2023.311
|
|
Citations to this article as recorded by
Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real‐World Cohort Study
Siwei Zheng, Xueyan Li, Hongli Liu, Tianhao Mao, You Ge, Wenjing Ji, Xixuan Wang, Yijun Bao, Yu Zhang, Anling Zhou, Qunzeng Danzeng, Jialuo Wang, Feng Yang, Qingfang Xiong, Yongfeng Yang
Journal of Viral Hepatitis.2026;[Epub] CrossRef Entecavir in Hepatitis B Treatment: A 25-Year Bibliometric Journey (2001-2025) Through Trends, Themes, and Therapeutic Advances
Mohammed Alquhaidan, Ibrahim Albokhadaim, Yassir A. Almofti, Mohammed Al-Rasheed, Maryam Mahmoud, Alaa Azhari, Afzal A. Assif, Mahmoud Kandeel
International Journal of Nutrition, Pharmacology, Neurological Diseases.2025; 15(4): 438. CrossRef
|